Prestige Consumer Healthcare Inc (PBH) financials

NYSE · Health Care

$49.06 +0.64% Close Oct 30, 2026 Live

Prestige Consumer Healthcare revenue and earnings by year

Prestige Consumer Healthcare's revenue was $1.09 billion in the fiscal year to March 31, 2026, down 4.3% from the year before. Net income was $190 million, 17.5% of revenue. Since the fiscal year to March 31, 2017, revenue has grown 2.4% a year on average.

RevenueNet income
$0$500M$1.00B
2017201820192020202120222023202420252026

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue1.091.141.131.131.090.940.960.981.040.88
Revenue growth-4.3%1.1%-0.2%3.8%15.2%-2.0%-1.3%-6.3%18.0%—
Gross profit0.600.630.620.630.620.550.550.560.580.50
Gross margin54.7%55.8%55.5%55.4%57.1%58.0%57.3%56.9%55.4%56.7%
Operating income0.310.340.34-0.020.330.300.290.070.220.26
Operating margin28.4%29.6%30.4%-2.0%30.4%31.5%30.2%6.8%20.7%29.2%
Net income0.190.210.21-0.080.210.160.14-0.040.340.07
Net margin17.5%18.9%18.6%-7.3%18.9%17.5%14.8%-3.7%32.6%7.9%
Diluted EPS$3.91$4.29$4.17-$1.65$4.04$3.25$2.78-$0.71$6.33$1.30
Free cash flow0.250.240.240.220.250.210.200.180.200.15

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PBH in Markets.

See also: PBH valuation and P/E history · PBH returns

No forecast, no recommendation. This page describes Prestige Consumer Healthcare Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.